ID

15296

Description

Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00143871

Lien

https://clinicaltrials.gov/show/NCT00143871

Mots-clés

  1. 25/05/2016 25/05/2016 -
Téléchargé le

25 mai 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Lymphoma, Non-Hodgkin's NCT00143871

Eligibility Lymphoma, Non-Hodgkin's NCT00143871

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically documented, aggressive and/ or intermediate grade and high-grade b cell nhl, cd20 positive.
Description

b-cell NHL

Type de données

boolean

Alias
UMLS CUI [1]
C1512431
UMLS CUI [2]
C1512858
in relapse after primary conventional chemotherapy
Description

chemotherapy

Type de données

boolean

Alias
UMLS CUI [1]
C0392920
tumor sensitive (at least a partial response) to induction chemotherapy and/ or radiation therapy after treatment for relapse
Description

tumor sensitive

Type de données

boolean

Alias
UMLS CUI [1,1]
C1704632
UMLS CUI [1,2]
C0392920
UMLS CUI [2,1]
C1704632
UMLS CUI [2,2]
C1522449
treatment of cns or meningeal disease (cytology-negative csf) if present
Description

treatment of cns or meningeal disease

Type de données

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0007682
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0154728
cumulative total doxorubicin dosage <500 mg/m2
Description

doxorubicin dosage

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013089
UMLS CUI [1,2]
C0178602
performance score: 0-2
Description

performance score

Type de données

boolean

Alias
UMLS CUI [1]
C1518965
prior malignancies eligible if treated for cure and without active disease
Description

prior malignancies

Type de données

boolean

Alias
UMLS CUI [1]
C0006826
patients must not be pregnant or nursing.
Description

pregnant or nursing

Type de données

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
prior immunotherapy is allowed
Description

prior immunotherapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021083
UMLS CUI [1,2]
C0332152
signed informed consent
Description

signed informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
absolute neutrophil count > 1500/ µl, platelet count >100,000/ µl
Description

neutrophil count and platelet count

Type de données

boolean

Alias
UMLS CUI [1]
C0200633
UMLS CUI [2]
C0005821
bilirubin <1.5 x normal, sgot <2.5 x normal
Description

bilirubin and sgot

Type de données

boolean

Alias
UMLS CUI [1]
C0005437
UMLS CUI [2]
C0201899
serum creatinine <1.5 mg/dl
Description

serum creatinine

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
ejection fraction > 45% or > 40% with normal wall motion
Description

ejection fraction

Type de données

boolean

Alias
UMLS CUI [1]
C0232174
hiv negative
Description

hiv negative

Type de données

boolean

Alias
UMLS CUI [1]
C0481430
fev1, dlco > 50% predicted
Description

fev1

Type de données

boolean

Alias
UMLS CUI [1]
C0748133
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or nursing
Description

pregnant or nursing

Type de données

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147

Similar models

Eligibility Lymphoma, Non-Hodgkin's NCT00143871

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
b-cell NHL
Item
histologically documented, aggressive and/ or intermediate grade and high-grade b cell nhl, cd20 positive.
boolean
C1512431 (UMLS CUI [1])
C1512858 (UMLS CUI [2])
chemotherapy
Item
in relapse after primary conventional chemotherapy
boolean
C0392920 (UMLS CUI [1])
tumor sensitive
Item
tumor sensitive (at least a partial response) to induction chemotherapy and/ or radiation therapy after treatment for relapse
boolean
C1704632 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C1704632 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
treatment of cns or meningeal disease
Item
treatment of cns or meningeal disease (cytology-negative csf) if present
boolean
C0087111 (UMLS CUI [1,1])
C0007682 (UMLS CUI [1,2])
C0087111 (UMLS CUI [2,1])
C0154728 (UMLS CUI [2,2])
doxorubicin dosage
Item
cumulative total doxorubicin dosage <500 mg/m2
boolean
C0013089 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
performance score
Item
performance score: 0-2
boolean
C1518965 (UMLS CUI [1])
prior malignancies
Item
prior malignancies eligible if treated for cure and without active disease
boolean
C0006826 (UMLS CUI [1])
pregnant or nursing
Item
patients must not be pregnant or nursing.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
prior immunotherapy
Item
prior immunotherapy is allowed
boolean
C0021083 (UMLS CUI [1,1])
C0332152 (UMLS CUI [1,2])
signed informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
neutrophil count and platelet count
Item
absolute neutrophil count > 1500/ µl, platelet count >100,000/ µl
boolean
C0200633 (UMLS CUI [1])
C0005821 (UMLS CUI [2])
bilirubin and sgot
Item
bilirubin <1.5 x normal, sgot <2.5 x normal
boolean
C0005437 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
serum creatinine
Item
serum creatinine <1.5 mg/dl
boolean
C0201976 (UMLS CUI [1])
ejection fraction
Item
ejection fraction > 45% or > 40% with normal wall motion
boolean
C0232174 (UMLS CUI [1])
hiv negative
Item
hiv negative
boolean
C0481430 (UMLS CUI [1])
fev1
Item
fev1, dlco > 50% predicted
boolean
C0748133 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnant or nursing
Item
pregnant or nursing
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial